BR0211207A - Derivados de 2-(aminometil)-tetrahidro-9-oxa-1,3-diaza-ciclopenta[ a]naftalenila com atividade antipsicótica - Google Patents

Derivados de 2-(aminometil)-tetrahidro-9-oxa-1,3-diaza-ciclopenta[ a]naftalenila com atividade antipsicótica

Info

Publication number
BR0211207A
BR0211207A BR0211207-8A BR0211207A BR0211207A BR 0211207 A BR0211207 A BR 0211207A BR 0211207 A BR0211207 A BR 0211207A BR 0211207 A BR0211207 A BR 0211207A
Authority
BR
Brazil
Prior art keywords
diaza
cyclopenta
oxa
aminomethyl
tetrahydro
Prior art date
Application number
BR0211207-8A
Other languages
English (en)
Inventor
Richard Eric Mewshaw
Rulin Zhao
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BR0211207A publication Critical patent/BR0211207A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

"DERIVADOS DE 2-(AMINOMETIL)-TETRAHIDRO-9-OXA-1,3-DIAZA-CICLOPENTA[ a]NAFTALENILA COM ATIVIDADE ANTIPSICóTICA". A presente invenção refere-se a compostos de Fórmula (I), que são úteis no tratamento de distúrbios associados com desregulagem de dopamina.
BR0211207-8A 2001-07-20 2002-07-19 Derivados de 2-(aminometil)-tetrahidro-9-oxa-1,3-diaza-ciclopenta[ a]naftalenila com atividade antipsicótica BR0211207A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30693101P 2001-07-20 2001-07-20
PCT/US2002/022981 WO2003008419A1 (en) 2001-07-20 2002-07-19 2-(AMINOMETHYL)-TETRAHYDRO-9-OXA-1,3-DIAZA-CYCLOPENTA[a]NAPHTHALENYL DERIVATIVES WITH ANTIPSYCHOTIC ACTIVITY

Publications (1)

Publication Number Publication Date
BR0211207A true BR0211207A (pt) 2004-07-13

Family

ID=23187510

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0211207-8A BR0211207A (pt) 2001-07-20 2002-07-19 Derivados de 2-(aminometil)-tetrahidro-9-oxa-1,3-diaza-ciclopenta[ a]naftalenila com atividade antipsicótica

Country Status (12)

Country Link
US (1) US6541502B1 (pt)
EP (1) EP1421086B1 (pt)
JP (1) JP2004537556A (pt)
CN (1) CN100369916C (pt)
AT (1) ATE338046T1 (pt)
BR (1) BR0211207A (pt)
CA (1) CA2454543A1 (pt)
DE (1) DE60214397T2 (pt)
DK (1) DK1421086T3 (pt)
ES (1) ES2271314T3 (pt)
MX (1) MXPA04000581A (pt)
WO (1) WO2003008419A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201412727A (zh) * 2012-08-24 2014-04-01 Daiichi Sankyo Co Ltd 具有鏈狀側鏈之色酮衍生物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4135474A1 (de) 1991-10-28 1993-04-29 Bayer Ag 2-aminomethyl-chromane
DE4140540A1 (de) 1991-12-09 1993-06-17 Bayer Ag Neue azaheterocyclylmethyl-chromane
US5756532A (en) 1995-11-06 1998-05-26 American Home Products Corporation Aminomethyl-2 3 8 9-tetrahydro-7H-1 4-dioxino 2 3-E!-indol-8-ones and derivatives
IL119483A (en) * 1995-11-06 1999-06-20 American Home Prod 2-(Aminomethyl)-3,4,7,9- tetrahydro- 2H-pyrano-2[3,3-e]indol-8-ones their derivatives and pharmaceutical compositions containing them
US5750556A (en) 1996-10-30 1998-05-12 American Home Products Corporation 2-(aminomethyl)-3,4,7,9-tetrahydro-2H-pyrano- 2,3-E!indol-8-ones and derivatives
EP0973749A1 (en) 1997-02-18 2000-01-26 American Home Products Corporation 4-aminoalkoxy-1h-benzimidazole derivatives, their preparation and their use as dopamine autoreceptor (d2) agonists

Also Published As

Publication number Publication date
US6541502B1 (en) 2003-04-01
MXPA04000581A (es) 2004-04-20
CA2454543A1 (en) 2003-01-30
WO2003008419A1 (en) 2003-01-30
DE60214397T2 (de) 2007-10-11
CN1555377A (zh) 2004-12-15
ES2271314T3 (es) 2007-04-16
EP1421086A1 (en) 2004-05-26
CN100369916C (zh) 2008-02-20
DK1421086T3 (da) 2006-12-11
JP2004537556A (ja) 2004-12-16
EP1421086B1 (en) 2006-08-30
DE60214397D1 (en) 2006-10-12
ATE338046T1 (de) 2006-09-15

Similar Documents

Publication Publication Date Title
ATE324371T1 (de) N-substituierte heterocyclische nichtaryl- nmda/nr2b-antagonisten
SE9900100D0 (sv) New compounds
CY1113578T1 (el) 2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια
ECSP045081A (es) Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados
ATE363463T1 (de) 2-(2,6-dichlorphenyl)-diarylimidazole
NO20052787L (no) N-alkyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
EA200600203A1 (ru) Производные 2-(хиноксалин-5-илсульфониламино)бензамида в качестве модуляторов сск2
EP1764092A3 (en) Selecting compounds for treatment of Alzheimer's disease
NO20062629L (no) Oksazolderivater av tetrackliner
NO20052788L (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
ES2187261B2 (es) Compuestos de eteres y amidas y su preparacion, como agentes anti-diabeticos.
NO20052908D0 (no) Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents.
BRPI0409276A (pt) derivados de piperazina inibidores de renina
BRPI0417858A (pt) composto, composição farmacêutica, e, uso de uma composição farmacêutica
AU2003249535A1 (en) 1,6-fused uracil derivatives as matrix metalloproteinase inhibitors
BRPI0415034A (pt) derivados de aminopiridina como inibidores de não-sintase induzìveis
ATE515266T1 (de) 2-(amino-3,4-dioxo-1-cyclobuten-1- yl)aminoalkylsäure-derivate für die schmerzbehandlung
AU2002365288A1 (en) Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases
BR0211207A (pt) Derivados de 2-(aminometil)-tetrahidro-9-oxa-1,3-diaza-ciclopenta[ a]naftalenila com atividade antipsicótica
AU2003250465A1 (en) 5,6-fused uracil derivatives as matrix metalloproteinase inhibitors
BR0211340A (pt) Derivados de 2-(aminometil)-tetraidro-9-oxa-1,3-diaza-ciclopenta[a ]naftalenila com atividade antipsicótica
AR027349A1 (es) Derivados de amidas heterociclicas
ATE491709T1 (de) Pyrrolidinohydrochinazoline
MXPA05009243A (es) N-aril-2-oxazolidinona-5-carboxamidas y sus derivados.

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A E 9A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011.